2 active not recruiting, 2 completed, 1 recruiting. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Active not recruiting 2, Completed 2, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow VIR-3434: new trials by email Literature Review of VIR-3434 trials Research Report on VIR-3434
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection Tobevibart, Elebsiran, Bulevirtide - Viral Hepatitis | Phase 2 | Active not recruiting | Vir Biotechnology, Inc. | 100 | 2025-08-05 | 2026-01-16 |
| Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION] VIR-3434 - Hepatitis B, Chronic | Phase 2 | Recruiting | University Health Network, Toronto | 15 | 2024-03-13 | 2025-05-29 |
| A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B Infection VIR-3434, VIR-2218, TDF - Hepatitis B, Chronic | Phase 1 / Phase 2 | Completed | Vir Biotechnology, Inc. | 33 | 2023-05-10 | 2026-02-09 |
| SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection. VIR-2218, VIR-3434, NRTI - Hepatitis D, Chronic | Phase 2 | Active not recruiting | Vir Biotechnology, Inc. | 95 | 2022-09-17 | 2026-06-26 |
| Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection VIR-2218, VIR-3434, PEG-IFNα - Hepatitis B, Chronic | Phase 2 | Completed | Vir Biotechnology, Inc. | 244 | 2021-07-11 | 2026-04-23 |
Hepatitis (4) · Hepatitis B, Chronic (3) · Hepatitis B (2) · Hepatitis D (2) · Hepatitis D, Chronic (2) · Digestive System Diseases (1) · Liver Diseases (1)
Vir Biotechnology, Inc. (4) · University Health Network, Toronto (1)
Moldova (4) · Romania (4) · United Kingdom (4) · France (3) · Germany (3) · Bulgaria (2) · Canada (2) · Hong Kong (2) · Netherlands (2) · New Zealand (2) · South Korea (2) · Ukraine (2) · Belgium (1) · Italy (1) · Malaysia (1)
Jordan Feld, MD (1)